166 related articles for article (PubMed ID: 9443091)
1. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
Seo JH; Park BC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of the expression of IGF-2 and HBxAg in human hepatocellular carcinoma and liver cirrhosis].
Zhang JF; Liu YF; Su Q
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):282-4. PubMed ID: 7874760
[TBL] [Abstract][Full Text] [Related]
4. [Preparation of monoclonal antibody directed against hepatitis B virus X protein and detection of reactive antigen in hepatocellular carcinoma].
Li J; Tang ZY; Liu KD; Schroder CH
Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):533-5, 582. PubMed ID: 7842349
[TBL] [Abstract][Full Text] [Related]
5. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
6. [The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].
Shen LJ; Guo W; Gao P; Yu J; Qian ZY; Zhang HX; Zhang ZJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):227-30. PubMed ID: 22475145
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of hepatitis B virus X antigen expression in chronic hepatitis B and cirrhosis].
Huang Y; Wu G; Wang X
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):235-8. PubMed ID: 7587601
[TBL] [Abstract][Full Text] [Related]
8. [A study of the relationship between expression of IGF-II, IGF-IIR, HBxAg and the DNA ploidy, cell cycle of hepatocytes in hepatocarcinoma].
Deng T; Chen NL; Jia KM
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):743-6. PubMed ID: 7600862
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression.
Su Q; Liu YF; Zhang JF; Zhang SX; Li DF; Yang JJ
Hepatology; 1994 Oct; 20(4 Pt 1):788-99. PubMed ID: 7927218
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.
Wang XZ; Chen XC; Chen YX; Zhang LJ; Li D; Chen FL; Chen ZX; Chen HY; Tao QM
World J Gastroenterol; 2003 Dec; 9(12):2671-5. PubMed ID: 14669310
[TBL] [Abstract][Full Text] [Related]
11. [Expression of hepatitis B virus X protein in tumor and nontumor tissues of patients with hepatocellular carcinoma (HCC)].
Chen L
Zhonghua Yi Xue Za Zhi; 1992 Apr; 72(4):219-21, 254-5. PubMed ID: 1327450
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma.
Park BC; Huh MH; Seo JH
J Hepatol; 1995 Mar; 22(3):286-94. PubMed ID: 7608479
[TBL] [Abstract][Full Text] [Related]
13. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma.
d'Arville CN; Nouri-Aria KT; Johnson P; Williams R
Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351
[TBL] [Abstract][Full Text] [Related]
14. [Significance and expression of insulin-like growth factor II and its receptor in hepatocellular carcinogenesis].
Fan Z; Yang D; Qin H
Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):84-6. PubMed ID: 10861110
[TBL] [Abstract][Full Text] [Related]
15. [Expression of mutant p53 in chronic HBV infection and hepatocellular carcinoma].
Chen Y; Tang ZY; Li J
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):184-7. PubMed ID: 7956695
[TBL] [Abstract][Full Text] [Related]
16. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas.
Greenblatt MS; Feitelson MA; Zhu M; Bennett WP; Welsh JA; Jones R; Borkowski A; Harris CC
Cancer Res; 1997 Feb; 57(3):426-32. PubMed ID: 9012469
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody.
Pál J; Somogyi C; Szmolenszky A A; Szekeres G; Sípos J; Hegedüs G; Martzinovits I; Molnár J; Németh P
Pathol Oncol Res; 2001; 7(3):178-84. PubMed ID: 11692143
[TBL] [Abstract][Full Text] [Related]
18. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis.
Wang WL; London WT; Lega L; Feitelson MA
Hepatology; 1991 Jul; 14(1):29-37. PubMed ID: 1712339
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.
Wang WL; London WT; Feitelson MA
Cancer Res; 1991 Sep; 51(18):4971-7. PubMed ID: 1654208
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
